Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
metformin acetyl-coa carboxylase 2 NA Successful target TTD , DGIDB Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.56 approved unknown
metformin acetyl-coa carboxylase 2 NA Successful target TTD , DGIDB Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.56 approved unknown
metformin electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial small molecule NA drugbank Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved inhibitor
metformin electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial small molecule NA drugbank Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
metformin glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic small molecule NA drugbank Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
metformin glycerol-3-phosphate dehydrogenase [nad(+)], cytoplasmic small molecule NA drugbank Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved inhibitor
metformin 5'-amp-activated protein kinase subunit beta-1 small molecule NA drugbank , DGIDB Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.69 approved inducer,activator
metformin 5'-amp-activated protein kinase subunit beta-1 small molecule NA drugbank , DGIDB Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 4.69 approved inducer,activator
metformin solute carrier family 47 member 1 NA Successful target TTD , DGIDB Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 3.77 approved unknown
metformin solute carrier family 47 member 1 NA Successful target TTD , DGIDB Diagnosis[MeSHID:D003933]
Patient Discharge[MeSHID:D010351]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.77 approved unknown
click here to return to the previous page